Skip to main content
Publication date
2017 05
Authors
Borisov, SE Dheda, K Enwerem, M Leyet, RR D'Ambrosio, L Centis, R Sotgiu, G Tiberi, S Alffenaar, JW Maryandyshev, A Belilovski, E Ganatra, S Skrahina, A Akkerman, O Aleksa, A Amale, R Artsukevich, J Bruchfeld, J Caminero, JA Martinez, IC Codecasa, L Dalcolmo, M Denholm, J Douglas, P Duarte, R Esmail, A Fadul, M Filippov, A Forsman, LD Gaga, M Garcia-Fuertes, JA Garcia-Garcia, JM Gualano, G Jonsson, J Kunst, H Lau, JS Mastrapa, BL Troya, JLT Manga, S Manika, K Montaner, PG Mullerpattan, J Oelofse, S Ortelli, M Palmero, DJ Palmieri, F Papalia, A Papavasileiou, A Payen, MC Pontali, E Cordeiro, CR Saderi, L Sadutshang, TD Sanukevich, T Solodovnikova, V Spanevello, A Topgyal, S Toscanini, F Tramontana, AR Udwadia, ZF Viggiani, P White, V Zumla, A Migliori, GB
Author KI Usernames
Bruchfeld, J|judbru Davies Forsman, L|linada Forsman, LD|linada Jonsson, J|jerjon
Pubmed ID
28529205
Journal
The European respiratory journal
Doctype
Article
KI Connection
Låg
Mesh SV
Antituberkulosmedel Behandlingsresultat Diarylquinoliner Extremt läkemedelsresistent tuberkulos HIV-infektioner Karbapenemer Klofazimin Kohortstudier Kombinationsbehandling Kvinnlig Linezolid Manlig Medelålders personer Människa Patientsäkerhet Retrospektiva studier Tuberkulos, läkemedelsresistent Upphostning Vuxna
Mesh EN
Antitubercular Agents Carbapenems Clofazimine Cohort Studies Diarylquinolines Drug Therapy, Combination Extensively Drug-Resistant Tuberculosis HIV Infections Linezolid Patient Safety Retrospective Studies Sputum Treatment Outcome Tuberculosis, Multidrug-Resistant
First date
2018-12-04T22:17:26.032Z